Detalhe da pesquisa
1.
Integrated epigenetic and transcriptional single-cell analysis of t(11;14) multiple myeloma and its BCL2 dependency.
Blood
; 143(1): 42-56, 2024 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37729611
2.
A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics.
Blood
; 143(13): 1242-1258, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096363
3.
Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population.
Blood Adv
; 8(7): 1737-1746, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212245
4.
Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone.
medRxiv
; 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38699307
5.
Exploring the impact of dexamethasone on gene regulation in myeloma cells.
Life Sci Alliance
; 6(9)2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37524526
6.
MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology.
Cancer Discov
; 13(2): 348-363, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477267
7.
Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors.
bioRxiv
; 2023 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37577538
8.
Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma.
Nat Med
; 29(9): 2295-2306, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37653344
9.
Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine.
Nat Rev Clin Oncol
; 19(4): 223-236, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35017721
10.
Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis.
Nat Commun
; 13(1): 7040, 2022 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36396631
11.
Molecular Signature of 18F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study.
J Nucl Med
; 63(7): 1008-1013, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086897
12.
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
Lancet Haematol
; 9(5): e340-e349, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344689
13.
DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma.
Clin Epigenetics
; 12(1): 163, 2020 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33138842
14.
Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes.
J Immunother Cancer
; 8(1)2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32001504